Skip to content
Catalyst

Zn(2+)Finding

Zn(2+) decreases alanine aminotransferase

lowersVery limited evidenceFinding

01 · The sentence it was drawn from

“Following a 16-week intervention, zinc supplementation compared with placebo significantly decreased serum alanine aminotransferase (ALT) concentrations and high-sensitivity C-reactive protein and considerably enhanced HDL-cholesterol values.”
Quoted verbatim from Effects of Zinc Supplementation on Inflammatory Status and Nonalcoholic Steatohepatitis in Overweight or Obese Children: a Randomized Clinical Trial.
This finding among the 65 findings on its endpoint

Zn(2+)

Alanine aminotransferase

lowers

Who
Overweight or obese children aged 10-18 years with nonalcoholic steatohepatitis
Dose studied
30 mg/day elemental zinc for 16 weeks

Very limited evidencePMID 37989929 · 2024

02 · The study

Study
RCT
Duration
4 months

Evidence, by strength

  • strong
  • moderate
  • limited
  • very limitedthis finding
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M6Z9YDXTRPYWR1YZ8DZYSNS8